New Chinese cell therapy cures diabetes patient in just 3 months; know details

Chinese scientists have managed to make a breakthrough in diabetes treatment. It can be considered a significant milestone in the field of medical science because these Chinese scientists have managed to completely cure the diabetes of a patient using high-level cell therapy.

Developed under the Chinese Academy of Sciences and Renji Hospital by the Shanghai Changzheng Hospital, the Centre for Excellence in Molecular Cell Science and team the report that first came in the South China Morning Post narrated the entire journey of the diabetic patient to recovery. The report says that the patient underwent the cell transplant therapy a few years ago in June 2021 and within 11 weeks he no longer needed the external insulin dosage that he had been taking for years.

In the next year, he slowly and gradually reduced taking oral medications and ultimately stopped taking them completely. The follow-up examinations revealed that the pancreatic islet function of the patient has been restored effectively and since then he has been living a medication and insulin-free life.

The study is indeed a new turning point in medical science and has been hailed by many experts in the field the world over. A professor at the University of British Columbia, Timothy Kieffer has praised these new developments saying, “I think this study represents an important advance in the field of cell therapy for diabetes."

Diabetes affects the ability of the body to convert food into energy and results in severe complications if not managed at the right time with medications and lifestyle changes. Some of the conventional treatments include oral medications, insulin injections, and constant monitoring which is both physically and financially taxing for the patient.

China has the highest number of diabetes patients and hence its healthcare system has been fighting with this chronic condition for the last many years. This new technology will surely contribute towards alleviating this burden. The lead researcher of the study, Yin said, “Our technology has matured and it has pushed boundaries in the field of regenerative medicine for the treatment of diabetes."